Register Login
Register to leave comments
  • News bot May 7, 2026, 8:17 p.m.

    📋 AMNEAL PHARMACEUTICALS, INC. (AMRX) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 16:09:04

    Event Type: Financial Results

    Event Details:

    AMNEAL PHARMACEUTICALS, INC. (AMRX) Reports the reporting period Financial Results AMNEAL PHARMACEUTICALS, INC. (AMRX) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 166017
    • Net Income: 89673
    • EPS: 0.27
    • Cash and equivalents: 197656

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Selling General Administrative 16.68K -2.65K $19.33K +729.91%
    Other Expense Income Interest Expense -53.36K -56.94K $3.58K +6.28%
    Other Expense Income Other Income Net 742.00 518.00 $224.00 +43.24%
    Current Assets Prepaid Expenses Other Current Assets 103.09K 98.39K $4.70K +4.77%
    Current Assets Property Equipment Net 444.61K 442.95K $1.66K +0.37%
    Current Assets Intangible Assets Net 534.87K 563.50K $-28.63K -5.08%
    Current Assets Operating Lease Right Of Use Assets 46.75K 38.83K $7.92K +20.39%
    Current Assets Other Assets 54.88K 57.80K $-2.92K -5.06%
    Current Liabilities Operating Lease Liabilities 41.10K 33.23K $7.87K +23.68%
    Current Liabilities Other Long Term Liabilities 2.77M 2.79M $-18.46K -0.66%
    Adjusted To Add Interest Expense 53.36K 56.94K $-3.58K -6.28%
    Prepaid Expenses and Other Current Assets 103.09K 98.39K $4.70K +4.77%
    Intangible Assets, Net 534.87K 563.50K $-28.63K -5.08%
    Other Assets 54.88K 57.80K $-2.92K -5.06%
    Accounts Payable 662.98K 662.98K $0.00 +0.00%
    Operating Lease Liabilities 8.92K 8.67K $254.00 +2.93%
    Noncontrolling Interests 85.91K 77.29K $8.62K +11.15%
    Revenue 722.52K 722.52K $0.00 +0.00%
    Selling, General & Administrative 138.86K -11.28K $150.14K +1330.92%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: AMNEAL PHARMACEUTICALS, INC.
    • Ticker Symbol: AMRX

Search

News categories